KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) EBT Margin (2016 - 2025)

Historic EBT Margin for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to 388.65%.

  • Novartis Ag's EBT Margin rose 3636700.0% to 388.65% in Q4 2025 from the same period last year, while for Dec 2025 it was 497.63%, marking a year-over-year increase of 4705200.0%. This contributed to the annual value of 29.99% for FY2025, which is 28800.0% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's EBT Margin is 388.65%, which was up 3636700.0% from 574.79% recorded in Q3 2025.
  • Novartis Ag's EBT Margin's 5-year high stood at 670.78% during Q1 2025, with a 5-year trough of 13.17% in Q3 2023.
  • Its 5-year average for EBT Margin is 125.67%, with a median of 24.88% in 2021.
  • In the last 5 years, Novartis Ag's EBT Margin plummeted by -1133000bps in 2022 and then surged by 6443200bps in 2025.
  • Novartis Ag's EBT Margin (Quarter) stood at 128.14% in 2021, then crashed by -88bps to 14.84% in 2022, then skyrocketed by 40bps to 20.81% in 2023, then rose by 20bps to 24.98% in 2024, then surged by 1456bps to 388.65% in 2025.
  • Its EBT Margin stands at 388.65% for Q4 2025, versus 574.79% for Q3 2025 and 423.06% for Q2 2025.